KAREN BAXTER: Open Payments
NPI 1588727317 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 36 payments from 9 companies in 2025. Trend: 2023 $1,428 · 2024 $431 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $386 |
| Lilly USA, LLC | 6 | $229 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| ABBVIE INC. | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: Wegovy, Ozempic, KISUNLA, AIRSUPRA, JARDIANCE, Rybelsus, MOUNJARO, QULIPTA.
Industry payments across TX — which companies pay providers there.
